KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy

被引：0
|
作者：
Lakmini Mudduwa
Harshini Peiris
Shania Gunasekara
Deepthika Abeysiriwardhana
Nimsha Liyanage
Suresh K. Rayala
Thusharie Liyanage
机构：
[1] University of Ruhuna,Department of Pathology, Faculty of Medicine
[2] University of Ruhuna,Medical Laboratory Science Degree Programme, Faculty of Medicine
[3] Indian Institute of Technology Madras (IITM),Department of Biotechnology
来源：
BMC Cancer | / 18卷
关键词：
ER; Endocrine therapy; Breast cancer; KIBRA; Recurrence free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Prognostic Role of Tumor Budding in Breast Cancer Patients Receiving Neo-Adjuvant Therapy
    Mozarowski, Paul
    Rasaiah, Bhubendra
    Reed, Melissa
    Lewis, Alexis
    Walde, Natalie
    Voutsadakis, Ioannis A.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 10
  • [32] Evolution in sites of recurrence over time in breast cancer patients treated with adjuvant endocrine therapy
    Algorashi, Ibrahim
    Goldvaser, Hadar
    Ribnikar, Domen
    Cescon, David W.
    Amir, Eitan
    CANCER TREATMENT REVIEWS, 2018, 70 : 138 - 143
  • [33] Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy
    Denison, U
    Baumann, J
    Peters-Engl, C
    Samonigg, H
    Krippl, P
    Lang, A
    Obermair, A
    Wagner, H
    Sevelda, P
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 (03) : 347 - 353
  • [34] Incidence of Anaemia in Breast Cancer Patients Receiving Adjuvant Chemotherapy
    Ursula Denison
    Jose Baumann
    Christian Peters-Engl
    Hellmut Samonigg
    Peter Krippl
    Alois Lang
    Andreas Obermair
    Helga Wagner
    Paul Sevelda
    Breast Cancer Research and Treatment, 2003, 79 : 347 - 353
  • [35] Adjuvant therapy in older patients with breast cancer
    Sawaki, Masataka
    ANNALS OF BREAST SURGERY, 2022, 6
  • [36] The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival
    B. B. Oven Ustaalioglu
    O. Balvan
    A. Bilici
    A. Develi
    M. Aliustaoglu
    F. A. Vardar
    B. Erkol
    Clinical and Translational Oncology, 2015, 17 : 895 - 902
  • [37] Weight trajectories in women receiving systemic adjuvant therapy for breast cancer
    Kirsten A. Nyrop
    Allison M. Deal
    Shlomit S. Shachar
    Jihye Park
    Seul Ki Choi
    Jordan T. Lee
    Erin A. O’Hare
    Amy Wheless
    Lisa A. Carey
    Hyman B. Muss
    Breast Cancer Research and Treatment, 2020, 179 : 709 - 720
  • [38] Weight trajectories in women receiving systemic adjuvant therapy for breast cancer
    Nyrop, Kirsten A.
    Deal, Allison M.
    Shachar, Shlomit S.
    Park, Jihye
    Choi, Seul Ki
    Lee, Jordan T.
    O'Hare, Erin A.
    Wheless, Amy
    Carey, Lisa A.
    Muss, Hyman B.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (03) : 709 - 720
  • [39] The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival
    Ustaalioglu, B. B. Oven
    Balvan, O.
    Bilici, A.
    Develi, A.
    Aliustaoglu, M.
    Vardar, F. A.
    Erkol, B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (11) : 895 - 902
  • [40] The Role of Community Pharmacists in Addressing Medication-related Issues for Breast Cancer Patients Receiving Adjuvant Endocrine Therapy
    Mokbel, Kinan
    Mokbel, Kefah
    ANTICANCER RESEARCH, 2022, 42 (02) : 661 - 666
12345